Effect of quercetin and its glucuronide metabolite upon 6-hydorxydopamine-induced oxidative damage in Neuro-2a cells

Free Radical Research

Volumn 46, Issue 8, 2012, Pages 1019-1028

  Mukai, Rie ^a   Kawabata, Kyuichi ^b   Otsuka, Seiko ^a   Ishisaka, Akari ^a   Kawai, Yoshichika ^c   Ji, Zai Si ^d   Tsuboi, Hiroshi ^d   Terao, Junji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b FUKUI PREFECTURAL UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

^d MEIJI DAIRIES CORPORATION   (Japan)

Author keywords

6 hydroxydopamine; Oxidative stress; Parkinson disease; Quercetin; Quercetin 3 O d glucuronide

Indexed keywords

HYDROGEN PEROXIDE; OXIDOPAMINE; QUERCETIN; QUERCETIN 3BETA GLUCURONIDE; QUERCETIN AGLYCONE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; MICROGLIA; NEUROBLASTOMA CELL; OXIDATIVE STRESS; PARKINSON DISEASE; PROPHYLAXIS;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL TRANSPORT; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDROGEN PEROXIDE; MICE; NEURONS; OXIDATION-REDUCTION; OXIDATIVE STRESS; OXIDOPAMINE; QUERCETIN;

EID: 84863918773     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2012.673720     Document Type: Article

References (30)

1. Miean KH, Mohamed S. Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants. J Agric Food Chem 2001;49:3106-3112.
2. Scalbert A, Williamson G. Dietary intake and bioavailability of polyphenols. J Nutr 2000;130(8S Suppl):2073S-2085S.
3. Day AJ, Mellon F, Barron D, Sarrazin G, Morgan MR, Williamson G. Human metabolism of dietary fl avonoids: identifi cation of plasma metabolites of quercetin. Free Radic Res 2001;35:941-952.
4. Ishisaka A, Ichikawa S, Sakakibara H, Piskula MK, Nakamura T, Kato Y, et al. Accumulation of orally administered quercetin in brain tissue and its antioxidative effects in rats. Free Radic Biol Med 2011;51:1329-1336.
5. de Boer VC, Dihal AA, van der Woude H, Arts IC, Wolffram S, Alink GM, et al. Tissue distribution of quercetin in rats and pigs. J Nutr 2005;135:1718-1725.
6. Youdim KA, Shukitt-Hale B, Joseph JA. Flavonoids and the brain: interactions at the blood-brain barrier and their physiological effects on the central nervous system. Free Radic Biol Med 2004;37:1683-1693.
7. Youdim KA, Spencer JP, Schroeter H, Rice-Evans C. Dietary fl avonoids as potential neuroprotectants. Biol Chem 2002; 383:503-519.
8. Yoshino S, Hara A, Sakakibara H, Kawabata K, Tokumura A, Ishisaka A, et al. Effect of quercetin and glucuronide metabolites on the monoamine oxidase-A reaction in mouse brain mitochondria. Nutrition 2011; 27:847-852.
9. Lotharius J, Brundin P. Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. Nat Rev Neurosci 2002; 3:932-942.
10. Zhang J, Perry G, Smith MA, Robertson D, Olson SJ, Graham DG, et al. Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. Am J Pathol 1999;154:1423-1429.
11. Sechi G, Deledda MG, Bua G, Satta WM, Deiana GA, Pes GM, et al. Reduced intravenous glutathione in the treatment of early Parkinson's disease. Prog Neuropsychopharmacol Biol Psychiatry 1996; 20:1159-1170.
12. Blum D, Torch S, Lambeng N, Nissou M, Benabid AL, Sadoul R, et al. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol 2001;65:135-172.
13. Miyama A, Saito Y, Yamanaka K, Hayashi K, Hamakubo T and Noguchi N. Oxidation of DJ-1 induced by 6-hydroxydopamine decreasing intracellular glutathione. PLoS One 2011;6:e27883.
14. Angeles DC, Gan BH, Onstead L, Zhao Y, Lim KL, Dachsel J, et al. Mutations in LRRK2 increase phosphorylation of peroxiredoxin 3 exacerbating oxidative stress-induced neuronal death. Hum Mutat 2011;32:1390-1397.
15. Jenner P, Olanow CW. Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 1996; 47(6 Suppl 3): S161-S170.
16. Shirai M, Kawai Y, Yamanishi R, Kinoshita T, Chuman H, Terao J. Effect of a conjugated quercetin metabolite, quercetin 3-glucuronide, on lipid hydroperoxide-dependent formation of reactive oxygen species in differentiated PC-12 cells. Free Radic Res 2006;40:1047-1053.
17. Moon JH, Tsushida T, Nakahara K, Terao J. Identifi cation of quercetin 3-O-beta-D-glucuronide as an antioxidative metabolite in rat plasma after oral administration of quercetin. Free Radic Biol Med 2001;30:1274-1285.
18. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
19. Cohen G, Heikkila RE. The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents. J Biol Chem 1974;249:2447-2452.
20. Yamazaki M, Chiba K. Genipin exhibits neurotrophic effects through a common signaling pathway in nitric oxide synthaseexpressing cells. Eur J Pharmacol 2008;581:255-261.
21. Saito Y, Nishio K, Ogawa Y, Kinumi T, Yoshida Y, Masuo Y, et al. Molecular mechanisms of 6-hydroxydopamine-induced cytotoxicity in PC12 cells: Involvement of hydrogen peroxidedependent and-independent action. Free Radic Biol Med 2007;42:675-685.
22. Izumi Y, Sawada H, Sakka N, Yamamoto N, Kume T, Katsuki H, et al. p-Quinone mediates 6-hydroxydopamine-induced dopaminergic neuronal death and ferrous iron accelerates the conversion of p-quinone into melanin extracellularly. J Neurosci Res 2005;79:849-860.
23. Boots AW, Haenen GR, Bast A. Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol 2008;585:325-337.
24. Metodiewa D, Jaiswal AK, Cenas N, Dickancaite E, Segura-Aguilar J. Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product. Free Radic Biol Med 1999;26: 107-116.
25. Ossola B, Kaarainen TM, Raasmaja A, Mannisto PT. Timedependent protective and harmful effects of quercetin on 6-OHDA-induced toxicity in neuronal SH-SY5Y cells. Toxicology 2008;250:1-8.
26. Bieger J, Cermak R, Blank R, de Boer VC, Hollman PC, Kamphues J, et al. Tissue distribution of quercetin in pigs after long-term dietary supplementation. J Nutr 2008;138: 1417-1420.
27. Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 2005;8:752-758.
28. Fetler L, Amigorena S. Neuroscience. Brain under surveillance: the microglia patrol. Science 2005;309:392-393.
29. McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 1988;38:1285-1291.
30. Liu J, Hong Z, Ding J, Zhang J, Chen S. Predominant release of lysosomal enzymes by newborn rat microglia after LPS treatment revealed by proteomic studies. J Proteome Res 2008;7:2033-2049.